RYANNE WAAGE: Open Payments
NPI 1871896431 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 113 payments from 17 companies in 2025. Trend: 2023 $1,932 · 2024 $2,045 · 2025 $2,118
Food & beverage: $2,009Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $297 |
| ABBVIE INC. | 17 | $256 |
| Novartis Pharmaceuticals Corporation | 14 | $250 |
| Lilly USA, LLC | 11 | $226 |
| UCB, Inc. | 10 | $210 |
| GENZYME CORPORATION | 12 | $199 |
| Regeneron Healthcare Solutions, Inc. | 7 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $157 |
| Amgen Inc. | 5 | $119 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, EBGLYSS, ILUMYA, OTEZLA.
Industry payments across SD — which companies pay providers there.
